IDSA2026EN
Group A Streptococcal Pharyngitis
Zusammenfassung
IDSA Clinical Practice Guideline Update on Group A Streptococcal (GAS) Pharyngitis You are using an outdated browser. Please upgrade your browser to improve your experience and security. Advertisement Skip to nav Skip to content View All Guidelines CURRENT IDSA Clinical Practice Guideline Update on Group A Streptococcal (GAS) Pharyngitis Download PDF Copy Link Published October 14, 2025 Update History This is Part 1 of an update to the 2012 IDSA Guideline on Diagnosis and Management of Group A S
Kerninformationen
s are caused by viruses and resolve without specific therapy. However, pharyngitis is among the most common syndromes prompting outpatient antimicrobial therapy , 1 in part because it is difficult to distinguish viral infections from bacterial infections clinically. Streptococcus pyogenes is the eti...
suppurative and suppurative sequelae that can be severe . However, the literature assessing the degree of effect of antibiotic treatment in preventing these sequelae is primarily from studies that were performed before the modern era of randomized clinical trials , and the relevance of their conclus...
de financial cost as well as the adverse effects of unnecessary antibiotics for both individual patients and the public, including the impact of antibiotic use on the rates of antimicrobial resistance. Among the challenges in the assessment and management of patients presenting with sore throat are ...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
IDSA2025
IDSA: Group A Streptococcal Pharyngitis (2025)
Cochrane2020
Cochrane Review: Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat
WHO2024
WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease
Cochrane2021
Cochrane Review: Antibiotics for treatment of sore throat in children and adults
AWMF2020
Halsschmerzen
Cochrane2022
Cochrane Review: Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care
IQWiG2022
IQWiG V21-09: Evidenzrecherche zur S3-Leitlinie Therapie entzündlicher Erkrankungen der Gaumenmandeln / Tonsillitis
WHO2024